Moreover, MCL-1 protein expression levels are linked to poor outcome, are required for breast cancer development, and targeting of MCL-1 hampers triple-negative breast cancer development in vivo [30]. The gene discussed is MCL1; the disease is triple-negative breast carcinoma.